top of page

Emily Belarski Sheskey



Pediatric Ambulatory Care


PharmD: University of Michigan

Residency Training

PGY1: Indiana University Health
PGY2 Pediatrics: Riley Hospital for Children at IU Health

Emily Belarski Sheskey

Practice Interests

Transitions of care, pediatric neurology, pediatric transplant, pediatric lupus

Professional Affiliation

  • ASHP (2014 - Present)

  • 2022-2023 SCSS Pediatrics Advisory Group 

  • 2021-2022 New Practitioners Forum Executive Committee Member 

  • 2020-2021 New Practitioners Forum Membership & Outreach Advisory Group Chair 

  • 2020-2021 New Practitioners Forum Advisory Group Member 

  • Pediatric Pharmacy Association (2017 - Present)

  • 2022-2024 SCSS Pediatrics Advisory Group

Recent Publications

  • Belarski E, Pettit R. Outcomes of a methicillin-resistant Staphylococcus aureus (MRSA) eradication protocol in pediatric cystic fibrosis (CF) patients. Pediatric Pulmonology. 2020;55:654-659. 

  • Platt B, Belarski E, Manaloor J, Ofner S, Carroll A, et al. Comparison of risk of Recrudescent Fever in Children with Kawasaki Disease Treated with Intravenous Immunoglobulin and Low-Dose vs High-Dose Aspirin. JAMA Network Open. 2020;3(1):e1918565.

Academic and/or National Presentations

  • "Tracking   Outcomes of Pediatric Ambulatory Care Pharmacy Services" PPA Fall Conference. Sept 2023. ACPE accredited. 

  • Use the Nose! Intranasal Benzodiazepines for Outpatient Pediatric Status  Epilepticus. PPA Live Webinar. Mar 2021. ACPE accredited.

Current Research

  • Clinical and financial outcomes of a pediatric ambulatory pharmacist during the first year of outpatient clinical services.

bottom of page